Cinryze
HUMAN C1-ESTERASE INHIBITOR · KIT · Takeda Pharmaceuticals America, Inc.
Cinryze is a kit containing human c1-esterase inhibitor. Manufactured by Takeda Pharmaceuticals America, Inc..
Key Facts
- Brand Name
- Cinryze
- Generic Name
- HUMAN C1-ESTERASE INHIBITOR
- NDC Code (Product)
42227-083- Manufacturer
- Takeda Pharmaceuticals America, Inc.
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125267
- Marketing Start
- 01/15/2021
Recall History
No Recall HistoryFull Prescribing Information
Indications & Usage
USES: Assists in support of the pancreas.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Dosage & Administration
DIRECTIONS: • Adults: 2 to 3 sprays orally, three times daily. Children under twelve one half adult dosage. • Do not take within 15 minutes of consuming food, beverage or brushing teeth. • Consult a physician for use in children under 12 years of age.
Warnings
WARNINGS: If pregnant or breast-feeding, ask a health professional before use. In case of overdose, get medical help or contact a Poison Control Center right away. If condition worsens, seek medical attention. KEEP OUT OF REACH OF CHILDREN Do not use if tamper evident seal is broken or missing. Store in a cool place after opening
Frequently Asked Questions
What is Cinryze used for?
Cinryze contains HUMAN C1-ESTERASE INHIBITOR. It is a kit taken as directed. Consult your doctor for specific uses.
Is Cinryze a controlled substance?
Cinryze is not classified as a controlled substance by the DEA.
What is the generic name for Cinryze?
The generic name for Cinryze is HUMAN C1-ESTERASE INHIBITOR. There are 3 other brand versions of HUMAN C1-ESTERASE INHIBITOR.
What is the NDC code for Cinryze ?
The NDC (National Drug Code) for Cinryze is 42227-083, listed by Takeda Pharmaceuticals America, Inc..